scholarly journals Prostate cancer-associated thrombotic microangiopathy: A case report and review of the literature

2021 ◽  
Vol 5 (1) ◽  
pp. 017-022
Author(s):  
Kharagjitsing HHS ◽  
te Boekhorst PAW ◽  
Durdu-Rayman Nazik

Background: Thrombotic microangiopathy (TMA) is a rare and life-threatening complication of prostate carcinoma. Whether plasma exchange has a role in treatment remains a subject of debate. Here we present a case followed by a systematic review of the literature on this subject. Case report: We describe a 69-year old patient presenting with TMA, which was associated with an underlying metastatic prostate carcinoma. We conducted a search of similar cases in literature. Results: Our patient was treated and responded well on plasma exchange. Systematic review of the literature showed 17 additional cases of TMA associated with prostate carcinoma of which eleven were treated with plasma exchange with mostly good response. Conclusion: Based on current data we cannot exclude a potential role for plasma exchange in prostate cancer associated TMA.

2020 ◽  
Vol 4 (8) ◽  
pp. 1756-1759
Author(s):  
Maverick Chan ◽  
William K. Silverstein ◽  
Anna Nikonova ◽  
Katerina Pavenski ◽  
Lisa K. Hicks

Key Points Bendamustine can cause severe autoimmune hemolytic anemia (AIHA), which may require plasma exchange and aggressive immunosuppression. Bendamustine-induced AIHA can be delayed, and many, but not all, cases report prior exposure to fludarabine.


2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Norifumi Hayashi ◽  
Keiichirou Okada ◽  
Yuko Tsuruyama ◽  
Yu Kagaya ◽  
Sho Kumano ◽  
...  

Abstract Background Thrombotic microangiopathy (TMA) in patients with connective tissue disease is rare but life-threatening. In particular, the survival rate of patients with dermatomyositis (DM) that develop TMA is low. The effectiveness of plasma exchange (PEX) therapy is unclear for the treatment of TMA secondary to DM. Case presentation We describe a case of a 28-year-old woman who developed severe DM complicated by aspiration pneumonia from dysphagia and acute kidney injury. The patient was unresponsive to corticosteroids and intravenous immunoglobulin (IVIG) therapy and developed TMA. In this case, immunofluorescence of skin biopsy revealed that complement activation was involved in the pathogenesis of DM. After 6 PEX therapies, thrombocytopenia improved. She was successfully treated by intensive care and PEX therapy. Conclusions PEX therapy was effective to treat TMA secondary to DM associated with complement activation.


1993 ◽  
Vol 41 (9) ◽  
pp. 983-985 ◽  
Author(s):  
Cynthia T. McMurtry ◽  
Michael Godschalk ◽  
Hartmut H. Malluche ◽  
Zhaopo Geng ◽  
Robert A. Adler

VASA ◽  
2020 ◽  
pp. 1-6 ◽  
Author(s):  
Marina Di Pilla ◽  
Stefano Barco ◽  
Clara Sacco ◽  
Giovanni Barosi ◽  
Corrado Lodigiani

Summary: A 49-year-old man was diagnosed with pre-fibrotic myelofibrosis after acute left lower-limb ischemia requiring amputation and portal vein thrombosis. After surgery he developed heparin-induced thrombocytopenia (HIT) with venous thromboembolism, successfully treated with argatroban followed by dabigatran. Our systematic review of the literature supports the use of dabigatran for suspected HIT.


2021 ◽  
Vol 87 ◽  
pp. 20-25
Author(s):  
Nivedha V. Kannapadi ◽  
Safwan O. Alomari ◽  
Giorgio Caturegli ◽  
Ali Bydon ◽  
Sung-Min Cho

Sign in / Sign up

Export Citation Format

Share Document